Glass House Brands Inc.
GLAS · XNYSCIK 1848731fmd_1W4RNMQHQC3QDT9Y63YBEG5M47Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2025, 6 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 48 | 63 | 85 | 161 | 201 | 182 |
| Rental revenue | – | – | – | – | 0 | – |
| Cost of revenue | 30 | 47 | 64 | 80 | 104 | 105 |
| Gross profit | 19 | 16 | 21 | 81 | 97 | 77 |
| Realized investment gains (losses) | (2) | (1) | (2) | – | – | – |
| Selling, general and administrative | 20 | 37 | 49 | 56 | 63 | 67 |
| Total operating expenses | 25 | 52 | 77 | 130 | 92 | 93 |
| Operating income | (6) | (36) | (56) | (50) | 6 | (17) |
| Interest expense | 2 | 3 | 8 | 10 | 9 | 7 |
| Other non-operating income (expense) | – | (5) | 19 | (39) | 5 | (0) |
| Income before taxes | (10) | (41) | (37) | (88) | 11 | (17) |
| Income tax expense | 6 | 2 | (4) | 10 | 10 | 12 |
| Net income from continuing operations | (17) | (43) | (33) | (98) | 1 | (29) |
| Net income | (17) | (43) | (33) | (98) | 1 | (30) |
| Net income to common shareholders | – | (45) | (53) | (117) | (15) | (45) |